CureVac to start global late-stage trial for COVID-19 vaccine in fourth quarter

Germany’s CureVac NV said on Tuesday it has started a mid-stage study testing its experimental coronavirus vaccine and plans to begin a much larger trial in the fourth quarter.

https://www.reuters.com/article/us-health-coronavirus-curevac-vaccine/curevac-to-start-global-late-stage-trial-for-covid-19-vaccine-in-fourth-quarter-idUSKBN26K3HQ